sözaltı news Health
Health
EN AZ
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

marketwatch.com 22.09.2026 17:46 30 views
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.
Similar stories 1 outlet
Optimising a digitally delivered behavioural weight loss programme: a factorial cluster randomised controlled trial nature.com 19.09.2026
Related stories
Rise in accidents involving kids and e-bikes sparks debate about regulation
Rise in accidents involving kids and e-bikes sparks debate about regulation
npr.org · 13.10
 Wake Up! Everyone Wants to Smell Like Coffee Right Now
Wake Up! Everyone Wants to Smell Like Coffee Right Now
cosmopolitan.com · 12.10
 I've woken from operations to find the surgery hasn't been done - women's health is broken
I've woken from operations to find the surgery hasn't been done - women's health is broken
bbc.co.uk · 12.10
 Sauna research gathers steam
Sauna research gathers steam
npr.org · 12.10
 Could Ezra Frech Be the Next Bachelor? Here’s What He Said About Those Rumors
Could Ezra Frech Be the Next Bachelor? Here’s What He Said About Those Rumors
cosmopolitan.com · 12.10
 Qantas flight grounded after bedbug outbreak
Qantas flight grounded after bedbug outbreak
bbc.co.uk · 12.10